Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)
Clinical trial NCT05064956 · COMPLETED
Trial details
- NCT number
- NCT05064956
- Sponsor
- London School of Hygiene and Tropical Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2021-11-17
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.